Technical Analysis for ABSI - Absci Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 4.21 | -3.22% | -0.14 |
ABSI closed down 3.22 percent on Friday, May 24, 2024, on 81 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Jun 12
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Bollinger Band Squeeze | Range Contraction | -3.22% | |
BB Squeeze + Lower Band Touch | Range Contraction | -3.22% | |
Below Lower BB | Weakness | -3.22% |
Alert | Time |
---|---|
Down 3% | 3 days ago |
Fell Below Previous Day's Low | 3 days ago |
60 Minute Opening Range Breakdown | 3 days ago |
Down 2 % | 3 days ago |
Rose Above Lower Bollinger Band | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/12/2024
Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Genscript Biotech
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Genscript Biotech
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.72 |
52 Week Low | 1.1111 |
Average Volume | 1,080,710 |
200-Day Moving Average | 3.26 |
50-Day Moving Average | 5.08 |
20-Day Moving Average | 4.83 |
10-Day Moving Average | 4.66 |
Average True Range | 0.37 |
RSI (14) | 35.90 |
ADX | 13.94 |
+DI | 17.36 |
-DI | 25.47 |
Chandelier Exit (Long, 3 ATRs) | 4.34 |
Chandelier Exit (Short, 3 ATRs) | 5.26 |
Upper Bollinger Bands | 5.35 |
Lower Bollinger Band | 4.31 |
Percent B (%b) | -0.1 |
BandWidth | 21.38 |
MACD Line | -0.17 |
MACD Signal Line | -0.11 |
MACD Histogram | -0.0568 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.62 | ||||
Resistance 3 (R3) | 4.65 | 4.54 | 4.55 | ||
Resistance 2 (R2) | 4.54 | 4.44 | 4.53 | 4.53 | |
Resistance 1 (R1) | 4.38 | 4.37 | 4.32 | 4.35 | 4.51 |
Pivot Point | 4.27 | 4.27 | 4.24 | 4.25 | 4.27 |
Support 1 (S1) | 4.10 | 4.16 | 4.05 | 4.07 | 3.91 |
Support 2 (S2) | 3.99 | 4.10 | 3.98 | 3.89 | |
Support 3 (S3) | 3.83 | 3.99 | 3.87 | ||
Support 4 (S4) | 3.80 |